SAPCD2 and neuroblastoma: Here we presented evidence that SAPCD2 (suppressor anaphase-promoting complex domain containing 2), which we showed as being suppressed in GSK-J4-treated neuroblastoma (NB) cells, was overexpressed in human neuroblastoma (NB) samples and was associated with NB progression and poor outcome of patients.